Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05056155 · ClinicalTrials.gov registry record · NA

Systane Complete Multi-symptom Relief

A NA study, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
119
Enrollment target

NCT05056155 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 119 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05056155, a NA study, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
119 participants
Enrollment target

Study Summary

The purpose of this study is to demonstrate effective symptom relief with the use of Systane Complete among subjects with dry eye disease (DED).

Interventions

  • OTHER Systane Complete

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2021-11-09
Est. Completion 2022-03-25
Phase NA

Sponsor

Alcon Research

275 total trials

What the Registry Record Tells You About NCT05056155

The ClinicalTrials.gov registry entry for NCT05056155 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Systane Complete is the first listed.

NCT05056155 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05056155 about?

NCT05056155 is a clinical study titled "Systane Complete Multi-symptom Relief". The purpose of this study is to demonstrate effective symptom relief with the use of Systane Complete among subjects with dry eye disease (DED).

What is the current status of trial NCT05056155?

This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2021-11-09. Estimated completion is 2022-03-25.

What interventions are being tested in trial NCT05056155?

The interventions under investigation include: Systane Complete (OTHER).

Who is sponsoring clinical trial NCT05056155?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.